Literature DB >> 22236188

Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells.

Kevin Goncalves1, Katie Sullivan, Shelley Phelan.   

Abstract

Peroxiredoxins are thiol-specific antioxidant proteins whose expression is elevated in several cancers. We compared the expression and function of Prdx1 and Prdx6 between the MCF-7 mammary adenocarcinoma cell line and the noncancerous MCF-10A cell line. We found elevated Prdx1 expression in MCF-7 cells and comparable expression of Prdx6. Suppression of Prdx1 and/or Prdx6 resulted in a modest increase in peroxide-induced cytotoxicity of MCF-7 cells, and a dramatic increase in MCF-10A cytotoxicity with and without hydrogen peroxide treatment. Our data confirm a cytoprotective role for peroxiredoxins and suggest a synergistic role for Prdx1 and Prdx6 in MCF-10A cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236188     DOI: 10.3109/07357907.2011.629382

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.

Authors:  José Díaz-Chávez; Miguel A Fonseca-Sánchez; Elena Arechaga-Ocampo; Ali Flores-Pérez; Yadira Palacios-Rodríguez; Guadalupe Domínguez-Gómez; Laurence A Marchat; Lizeth Fuentes-Mera; Guillermo Mendoza-Hernández; Patricio Gariglio; César López-Camarillo
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

2.  Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression.

Authors:  Hye Lim Lee; Mi Hee Park; Dong Ju Son; Ho Sueb Song; Jung Hyun Kim; Seong Cheol Ko; Min Jong Song; Won Hyoung Lee; Joo Hee Yoon; Young Wan Ham; Sang Bae Han; Jin Tae Hong
Journal:  Oncotarget       Date:  2015-09-08

Review 3.  New Challenges to Study Heterogeneity in Cancer Redox Metabolism.

Authors:  Rui Benfeitas; Mathias Uhlen; Jens Nielsen; Adil Mardinoglu
Journal:  Front Cell Dev Biol       Date:  2017-07-11

4.  Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene.

Authors:  Xianchun Sun; Lingting Kong; Bingshu Li; Yan Zhang; Haiyan Yang
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

5.  The Prognosis Of Peroxiredoxin Family In Breast Cancer.

Authors:  Gang Wang; Wan-Chao Zhong; Yi-Hui Bi; Si-Yue Tao; Hai Zhu; Hai-Xing Zhu; A-Man Xu
Journal:  Cancer Manag Res       Date:  2019-11-14       Impact factor: 3.989

6.  MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer.

Authors:  Qi J Guo; Jamie N Mills; Savannah G Bandurraga; Lourdes M Nogueira; Natalie J Mason; E Ramsay Camp; Amanda C Larue; David P Turner; Victoria J Findlay
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

Review 7.  Peroxiredoxin 1 - an antioxidant enzyme in cancer.

Authors:  Chenbo Ding; Xiaobo Fan; Guoqiu Wu
Journal:  J Cell Mol Med       Date:  2016-09-21       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.